GENEVA, July 6 -- JUVENTAS UNICARE PHARMACEUTICAL (BEIJING) CO., LTD. filed a patent application (CN2025/142827) for “BISPECIFIC CHIMERIC ANTIGEN RECEPTOR TARGETING BCMA-CD19 AND USE THEREOF”. With publication no. WO/2026/138580, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 19/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....